Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.

Santiago-Gómez A, Kedward T, Simões BM, Dragoni I, NicAmhlaoibh R, Trivier E, Sabin V, Gee JM, Sims AH, Howell SJ, Clarke RB.

Cancer Lett. 2019 Aug 28;458:66-75. doi: 10.1016/j.canlet.2019.05.014. Epub 2019 May 20.

2.

Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Byrne D, Daly C, Nicamhlaoibh R, Howlett A, Scanlon K, Clynes M.

Cytotechnology. 1998 Sep;27(1-3):113-36. doi: 10.1023/A:1008052401952.

3.

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.

Bone. 2005 Jan;36(1):159-72. Epub 2004 Nov 24.

PMID:
15664014
4.

[Does tumor angiogenesis play a role in bone metastatic process?].

Peyruchaud O, Serre CM, NicAmhlaoibh R, Sveigaard C, Clézardin P.

Rev Med Suisse Romande. 2004 Feb;124(2):83-4. French.

PMID:
15095619
5.

Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity.

Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P, Clezardin P.

J Biol Chem. 2003 Nov 14;278(46):45826-32. Epub 2003 Sep 3.

6.

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM.

J Bone Miner Res. 2003 May;18(5):859-67.

7.

Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.

Winding B, NicAmhlaoibh R, Misander H, Høegh-Andersen P, Andersen TL, Holst-Hansen C, Heegaard AM, Foged NT, Brünner N, Delaissé JM.

Clin Cancer Res. 2002 Jun;8(6):1932-9.

8.

Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro.

NicAmhlaoibh R, Shtivelman E.

Oncogene. 2001 Jan 11;20(2):270-5.

9.

Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.

NicAmhlaoibh R, Heenan M, Cleary I, Touhey S, O'Loughlin C, Daly C, Nuñez G, Scanlon KJ, Clynes M.

Int J Cancer. 1999 Jul 30;82(3):368-76.

10.

Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

Duffy CP, Elliott CJ, O'Connor RA, Heenan MM, Coyle S, Cleary IM, Kavanagh K, Verhaegen S, O'Loughlin CM, NicAmhlaoibh R, Clynes M.

Eur J Cancer. 1998 Jul;34(8):1250-9.

PMID:
9849488
11.

Recent developments in drug resistance and apoptosis research.

Clynes M, Daly C, NicAmhlaoibh R, Cronin D, Elliott C, O'Connor R, O'Doherty T, Connolly L, Howlett A, Scanlon K.

Crit Rev Oncol Hematol. 1998 Sep;28(3):181-205. Review. No abstract available.

PMID:
9793746
12.

Multidrug resistance in ocular melanoma.

McNamara M, Clynes M, Dunne B, NicAmhlaoibh R, Lee WR, Barnes C, Kennedy SM.

Br J Ophthalmol. 1996 Nov;80(11):1009-12.

Supplemental Content

Loading ...
Support Center